Dimensional Fund Advisors LP Crispr Therapeutics Ag Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 824,606 shares of CRSP stock, worth $33.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
824,606
Previous 950,149 13.21%
Holding current value
$33.6 Million
Previous $51.3 Million 24.49%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$44.62 - $62.75 $5.6 Million - $7.88 Million
-125,543 Reduced 13.21%
824,606 $38.7 Million
Q2 2024

Aug 09, 2024
BUY
$51.17 - $68.18 $977,039 - $1.3 Million
19,094 Added 2.05%
950,149 $51.3 Million
Q1 2024

May 10, 2024
BUY
$60.67 - $89.12 $9.2 Million - $13.5 Million
151,601 Added 19.45%
931,055 $63.5 Million
Q4 2023

Feb 07, 2024
SELL
$38.62 - $72.18 $3.88 Million - $7.24 Million
-100,347 Reduced 11.41%
779,454 $48.8 Million
Q3 2023

Nov 09, 2023
BUY
$45.39 - $59.0 $7.65 Million - $9.94 Million
168,530 Added 23.69%
879,801 $39.9 Million
Q2 2023

Aug 09, 2023
SELL
$43.47 - $67.77 $2.11 Million - $3.28 Million
-48,464 Reduced 6.38%
711,271 $39.9 Million
Q1 2023

May 12, 2023
SELL
$41.0 - $56.12 $618,116 - $846,065
-15,076 Reduced 1.95%
759,735 $34.4 Million
Q4 2022

Feb 09, 2023
BUY
$39.19 - $65.67 $4.93 Million - $8.26 Million
125,751 Added 19.37%
774,811 $31.5 Million
Q3 2022

Nov 10, 2022
BUY
$61.1 - $83.78 $12.8 Million - $17.5 Million
209,134 Added 47.54%
649,060 $42.4 Million
Q2 2022

Aug 12, 2022
BUY
$43.23 - $73.83 $8.64 Million - $14.8 Million
199,939 Added 83.31%
439,926 $26.7 Million
Q1 2022

May 13, 2022
SELL
$53.19 - $79.24 $1.01 Million - $1.51 Million
-19,054 Reduced 7.36%
239,987 $15.1 Million
Q4 2021

Feb 09, 2022
BUY
$70.09 - $111.29 $7.32 Million - $11.6 Million
104,371 Added 67.48%
259,041 $19.6 Million
Q3 2021

Nov 12, 2021
BUY
$110.2 - $156.64 $975,049 - $1.39 Million
8,848 Added 6.07%
154,670 $17.3 Million
Q2 2021

Aug 12, 2021
BUY
$100.84 - $161.89 $713,140 - $1.14 Million
7,072 Added 5.1%
145,822 $23.6 Million
Q1 2021

May 14, 2021
BUY
$110.72 - $210.04 $3.44 Million - $6.53 Million
31,103 Added 28.89%
138,750 $16.9 Million
Q4 2020

Feb 25, 2021
BUY
$79.67 - $173.23 $8.58 Million - $18.6 Million
107,647 New
107,647 $16.5 Million

Others Institutions Holding CRSP

# of Institutions
490
Shares Held
58M
Call Options Held
1.1M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.18B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email